Welcome
Support Centre
11 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Adjunctive Dietary Intervention study for Challenging Behaviour in people with an Intellectual Disability: a randomised double blind placebo controlled multicentre clinical trial
ISRCTN ISRCTN56149264
ClinicalTrials.gov identifier
Public title Adjunctive Dietary Intervention study for Challenging Behaviour in people with an Intellectual Disability: a randomised double blind placebo controlled multicentre clinical trial
Scientific title
Acronym ADICBID
Serial number at source SGUL/SWLSG 001
Study hypothesis Dietary intervention using multivitamins is able to reduce challenging behaviour in a learning disabled adult population.
Lay summary Not provided at time of registration
Ethics approval Not provided at time of registration.
Study design Randomised controlled trial
Countries of recruitment United Kingdom
Disease/condition/study domain Challenging behaviour in an intellectualy disabled population
Participants - inclusion criteria 1. People aged between 18 and 70
2. People with a learning disability able to show consent or assent to inclusion
3. Challenging behaviour with a frequency averaging at least once a month in the three months prior to admission to the study
4. Existing medication usage will be allowed during the trial. There is no need to stop or change medication that the client is already taking.
5. The person must be living in a setting where there is help to fill in diaries and someone from whom objective reports are available. This will include family, residential homes or inpatient centres
Participants - exclusion criteria 1. Explicit refusal to participate
2. Living independently
3. Acute Mental Illness (chronic stable mental illness is allowed)
4. Full autism diagnosis (this does not include single autistic features without the full diagnosis)
5. Vegetarian
6. Allergy to vitamins or fish oils
Anticipated start date 01/10/2006
Anticipated end date 01/10/2008
Status of trial Completed
Patient information material Not available in web format, please use the contact details below to request a patient information sheet
Target number of participants 200 (100 per group)
Interventions Active multivitamin compound versus placebo.

Please note that as of 17/09/2007 this trial was put on hold due to funding issues.
Primary outcome measure(s) Reduction in frequency and intensity of challenging behaviours
Secondary outcome measure(s) Improvements to quality of life and social functioning
Sources of funding No funding as of 17/09/2007
Trial website
Publications
Contact name Prof  Sheila  Hollins
  Address Division of Mental Health, Social and Developmental Psychiatry
St George's
Cranmer Terrace
Tooting
  City/town London
  Zip/Postcode SW17 0RE
  Country United Kingdom
  Tel +44 (0)208 725 5501
  Email shollins@sgul.ac.uk
Sponsor St George's, University of London (UK)
  Address Cranmer Terrace
Tooting
  City/town London
  Zip/Postcode SW17 0RE
  Country United Kingdom
  Tel +44 (0)208 672 9944
  Email rmukherj@sgul.ac.uk
  Sponsor website: http://www.sgul.ac.uk
Date applied 06/09/2005
Last edited 05/01/2012
Date ISRCTN assigned 07/10/2005
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central